Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL, Trosch R, Singer C, Brin MF, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M.
Brashear A, et al. Among authors: brin mf.
Neurology. 1999 Oct 22;53(7):1439-46. doi: 10.1212/wnl.53.7.1439.
Neurology. 1999.
PMID: 10534248
Clinical Trial.